Diaz J.H. Nephrotoxic Mushroom Poisoning: Global Epidemiology, Clinical Manifestations, and Management. Wilderness Environ Med. 2021;32(4):537-544.
Rationale
In the public mind "deadly mushroom" = death cap → liver. But there is a second target — the kidneys — with a different onset, different species and different management.
Methods
Narrative review of literature 1957–2021 on nephrotoxic mushroom poisonings and their management; classification by time to acute renal failure.
What it describes
Nephrotoxic groups:
- Orellanine webcaps (C. orellanus, C. rubellus et al.) — delayed nephrotoxicity: symptoms after 3–14 days, interstitial nephritis, chronic renal failure in survivors.
- "Accelerated" nephrotoxicity — Amanita proxima (Europe), A. smithiana (North America): acute renal failure within 1–3 days, without significant hepatitis.
- Rhabdomyolysis — Tricholoma equestre (the man-on-horseback): muscle breakdown → myoglobinuria → kidneys.
- Rare additions: Psilocybe cubensis by mass spectrometry — an uncommon cause of acute renal insufficiency.
Management: hemodialysis is often indicated (with orellanine the toxin barely clears); kidney transplantation is the fallback for irreversible injury.
Author's conclusions
The clinician should suspect a nephrotoxic mushroom in sudden renal failure after a "safe" forage: onset timing (days versus weeks) helps separate amanita from cortinarius.
Worth noting
The review completes Diaz-2005's syndromic scheme with "delayed" and "accelerated" renal failure — and explains why our webcap cards carry "poisonous" status even for species some guides call "conditionally edible": with orellanine there is no such thing as conditional edibility.